GUGGENHEIM CAPITAL LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 102 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$16,000
+220.0%
26,429
+123.5%
0.00%
Q2 2016$5,000
-61.5%
11,827
-7.6%
0.00%
Q1 2016$13,000
-80.0%
12,794
-41.9%
0.00%
Q4 2015$65,000
+41.3%
22,024
+51.1%
0.00%
Q3 2015$46,000
-23.3%
14,571
+42.8%
0.00%
Q2 2015$60,000
-45.9%
10,207
-17.3%
0.00%
Q2 2014$111,000
+26.1%
12,349
-24.9%
0.00%
Q1 2014$88,000
+151.4%
16,451
+19.2%
0.00%
Q4 2013$35,00013,7990.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders